Senti Biosciences

Senti Biosciences is a clinical-stage biotechnology company developing cell and gene therapies for difficult-to-treat diseases, especially cancer. The company uses its synthetic biology and gene-circuit platform to engineer controllable therapeutic candidates, including CAR-NK and other cell-based medicines.

Relationship details are part of the Pro plan.